Jain S, Paz E, Azem A
Genes (Basel). 2025; 15(12.
PMID: 39766801
PMC: 11675802.
DOI: 10.3390/genes15121534.
Zhao K, Zhou Z
Elife. 2024; 13.
PMID: 39269433
PMC: 11398859.
DOI: 10.7554/eLife.102355.
Sivasinprasasn S, Tocharus J, Mahatheeranont S, Nakrat S, Tocharus C
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204144
PMC: 11357448.
DOI: 10.3390/ph17081039.
Dadsena S, Cuevas Arenas R, Vieira G, Brodesser S, Melo M, Garcia-Saez A
Nat Commun. 2024; 15(1):4700.
PMID: 38830851
PMC: 11148036.
DOI: 10.1038/s41467-024-49067-6.
Li Y, Rasheed M, Liu J, Chen Z, Deng Y
Cells. 2024; 13(10.
PMID: 38786088
PMC: 11119937.
DOI: 10.3390/cells13100863.
Orexins in apoptosis: a dual regulatory role.
Cavalu S, Saber S, Hamad R, Abdel-Reheim M, Elmorsy E, Youssef M
Front Cell Neurosci. 2024; 18:1336145.
PMID: 38699177
PMC: 11064656.
DOI: 10.3389/fncel.2024.1336145.
Apoptotic dysregulation mediates stem cell competition and tissue regeneration.
Yusupova M, Ankawa R, Yosefzon Y, Meiri D, Bachelet I, Fuchs Y
Nat Commun. 2023; 14(1):7547.
PMID: 37985759
PMC: 10662150.
DOI: 10.1038/s41467-023-41684-x.
Mechanisms of BCL-2 family proteins in mitochondrial apoptosis.
Czabotar P, Garcia-Saez A
Nat Rev Mol Cell Biol. 2023; 24(10):732-748.
PMID: 37438560
DOI: 10.1038/s41580-023-00629-4.
Chromogranin B (CHGB) is dimorphic and responsible for dominant anion channels delivered to cell surface via regulated secretion.
Yadav G, Wang H, Ouwendijk J, Cross S, Wang Q, Qin F
Front Mol Neurosci. 2023; 16:1205516.
PMID: 37435575
PMC: 10330821.
DOI: 10.3389/fnmol.2023.1205516.
miRNA326-5p Targets DKC1 Gene to Regulate Apoptosis-Related Proteins and Intervene in the Development of Neuroblastoma.
Wang X, Zhang S, Wu H, Gao J, Wang L, Wang X
Anal Cell Pathol (Amst). 2023; 2023:6761894.
PMID: 37426487
PMC: 10329557.
DOI: 10.1155/2023/6761894.
Post-Translational Modification of Cysteines: A Key Determinant of Endoplasmic Reticulum-Mitochondria Contacts (MERCs).
Bassot A, Chen J, Simmen T
Contact (Thousand Oaks). 2023; 4:25152564211001213.
PMID: 37366382
PMC: 10243593.
DOI: 10.1177/25152564211001213.
Creation of distinctive Bax-lipid complexes at mitochondrial membrane surfaces drives pore formation to initiate apoptosis.
Clifton L, Wacklin-Knecht H, Aden J, Mushtaq A, Sparrman T, Grobner G
Sci Adv. 2023; 9(22):eadg7940.
PMID: 37267355
PMC: 10413641.
DOI: 10.1126/sciadv.adg7940.
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy.
Kouroumalis E, Tsomidis I, Voumvouraki A
Biomedicines. 2023; 11(4).
PMID: 37189787
PMC: 10135776.
DOI: 10.3390/biomedicines11041166.
Pore-Forming Proteins: From Pore Assembly to Structure by Quantitative Single-Molecule Imaging.
Margheritis E, Kappelhoff S, Cosentino K
Int J Mol Sci. 2023; 24(5).
PMID: 36901959
PMC: 10003378.
DOI: 10.3390/ijms24054528.
To not love thy neighbor: mechanisms of cell competition in stem cells and beyond.
Yusupova M, Fuchs Y
Cell Death Differ. 2023; 30(4):979-991.
PMID: 36813919
PMC: 10070350.
DOI: 10.1038/s41418-023-01114-3.
MAPK Cascade Signaling Is Involved in α-MMC Induced Growth Inhibition of Multiple Myeloma MM.1S Cells via G2 Arrest and Mitochondrial-Pathway-Dependent Apoptosis In Vitro.
Cai Z, Ye T, Jiang P, Liao Y, Wang L, Zhang Q
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678620
PMC: 9867419.
DOI: 10.3390/ph16010124.
The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis targeting CHOP and BAK which is augmented by cisplatin.
Kuang Y, He Z, Li L, Wang C, Cheng X, Shi Q
Int J Biol Sci. 2023; 19(1):120-136.
PMID: 36594085
PMC: 9760445.
DOI: 10.7150/ijbs.76345.
Biological properties of the BCL-2 family protein BCL-RAMBO, which regulates apoptosis, mitochondrial fragmentation, and mitophagy.
Kataoka T
Front Cell Dev Biol. 2023; 10:1065702.
PMID: 36589739
PMC: 9800997.
DOI: 10.3389/fcell.2022.1065702.
Pore-forming proteins as drivers of membrane permeabilization in cell death pathways.
Vandenabeele P, Bultynck G, Savvides S
Nat Rev Mol Cell Biol. 2022; 24(5):312-333.
PMID: 36543934
DOI: 10.1038/s41580-022-00564-w.
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis.
Bharti V, Watkins R, Kumar A, Shattuck-Brandt R, Mossing A, Mittra A
Cell Rep. 2022; 41(12):111826.
PMID: 36543138
PMC: 10030045.
DOI: 10.1016/j.celrep.2022.111826.